REGENXBIO Inc. Operating Leases, Future Minimum Payments, Due in Five Years
REGENXBIO Inc. (RGNX) had Operating Leases, Future Minimum Payments, Due in Five Years of $5.63 million as of 2018-12-31, per its 10-K filed 2020-02-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears · last filed 2020-02-26
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $5.63M.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Five Years $621.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Five Years $621.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Five Years $621.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Five Years |
|---|---|
| 2018-12-31 | $5.63M 10-K · filed 2020-02-26 |
| 2018-09-30 | $621.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $621.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $621.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $621.00K 10-K · filed 2018-03-06 |
| 2017-09-30 | $1.64M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $665.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $665.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $664.00K 10-K · filed 2017-03-07 |
| 2016-09-30 | $1.61M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.61M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.34M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $832.00K 10-K · filed 2016-03-03 |
| 2015-09-30 | $875.00K 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |